Search results for "hepatology"

showing 10 items of 2737 documents

One-step endoscopic removal of a giant double esophageal fibrovascular polyp

2014

medicine.medical_specialtyHepatologybusiness.industryGastroenterologymedicineMEDLINEpolypbusinessSurgery
researchProduct

Resection of intrahepatic cholangiocarcinoma

2016

medicine.medical_specialtyHepatologybusiness.industryGastroenterologymedicineRadiologybusinessIntrahepatic CholangiocarcinomaResectionHPB
researchProduct

Clinical outcomes with long-term sorafenib treatment: A multicenter, real-life study

2017

medicine.medical_specialtyHepatologybusiness.industryGastroenterologymedicineSorafenib treatmentIntensive care medicineLife studybusinessTerm (time)Digestive and Liver Disease
researchProduct

PA1 INFLIXIMAB AND TOPICAL TACROLIMUS ADMINISTRATION EFFECTIVE IN THE TREATMENT OF PYODERMA GANGRENOSUM

2009

medicine.medical_specialtyHepatologybusiness.industryGastroenterologymedicineTopical tacrolimusmedicine.diseasebusinessAdministration (government)DermatologyPyoderma gangrenosumInfliximabmedicine.drugDigestive and Liver Disease
researchProduct

FNDC5 rs3480 A>G polymorphism disentangles steatosis from fibrosis severity in patients with nonalcoholic fatty liver disease

2016

S. Petta1, L. Valenti2, R.M. Pipitone1, P. Dongiovanni2, C. Camma1, A.L. Fracanzani2, V. Di Marco1, M. Milano2, S. Grimaudo1, S. Fargion2, A. Craxi1 1 Section of Gastroenterology, Di.Bi.M.I.S., University of Palermo, Palermo, Italy 2 Department of Pathophysiology and Transplantation, Universita degli Studi, Internal Medicine, Fondazione Ca’ Granda IRCCS Ospedale Maggiore Policlinico, Milano, Italy

medicine.medical_specialtyHepatologybusiness.industryGastroenterologymedicine.diseaseGastroenterologyFNDC5TransplantationFibrosisInternal medicineNonalcoholic fatty liver diseaseMedicineIn patientSteatosisbusinessDigestive and Liver Disease
researchProduct

Functional gastrointestinal disorders: Dynamic observation of pediatric cases

2015

Introduction: Functional gastrointestinal disorders (FGID) are a variable set of clinical cases characterized by recurrent/chronic symptoms not associated with an organic pathology. These disorders are classified using the Rome III criteria. Objective: The study wanted to evaluate the prevalence by gender and age of FGIDs in a pediatric population recruited on the basis of recurrent/chronic abdominal pain, and to follow up patients for six months by administering questionnaires aimed at verifying any changes in symptoms. We also evaluated the possible involvement of factors responsible for these changes. Results: 62 patients between 4 and 17 years of age (27 males and 35 females) were inclu…

medicine.medical_specialtyHepatologybusiness.industryGastroenterologymedicine.diseaseGastroenterologyIntestinal motilityLiver diseaseSettore MED/38 - Pediatria Generale E SpecialisticaInternal medicineFGIDmedicineAnal sphincterbusinessDigestive and Liver Disease
researchProduct

Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial

2014

SummaryBackground A phase I dose-escalation trial of transarterial chemoembolisation (TACE) with idarubicin-loaded beads was performed in cirrhotic patients with hepatocellular carcinoma (HCC). Aim To estimate the maximum-tolerated dose (MTD) and to assess safety, efficacy, pharmacokinetics and quality of life. Methods Patients received a single TACE session with injection of 2 mL drug-eluting beads (DEBs; DC Bead 300–500 μm) loaded with idarubicin. The idarubicin dose was escalated according to a modified continuous reassessment method. MTD was defined as the dose level closest to that causing dose-limiting toxicity (DLT) in 20% of patients. Results Twenty-one patients were enrolled, inclu…

medicine.medical_specialtyHepatologybusiness.industryGastroenterologymedicine.diseaseGastroenterologyPharmacokinetic analysisSurgeryPharmacokineticsInternal medicineHepatocellular carcinomaToxicitymedicineIdarubicinPharmacology (medical)Myocardial infarctionbusinessAdverse effectObjective responsemedicine.drugAlimentary Pharmacology & Therapeutics
researchProduct

Recomendaciones del Club Español Pancreático para el diagnóstico y tratamiento de la pancreatitis crónica: parte 2 (tratamiento).

2013

Chronic pancreatitis (CP) is a complex disease with a wide spectrum of clinical manifestations ranging from asymptomatic disease to disabling forms or serious complications. The management of CP frequently differs among geographical areas and even among centers. These differences are due to the scarcity of high-quality studies and clinical practice guidelines that focus on the diagnosis and treatment of this disease. The aim of the Spanish Pancreatic Club was to create evidence-based recommendations for the management of CP. Two coordinators chose a multidisciplinary panel of 24 experts in this disease. These experts were selected on the basis of their clinical and research experience in CP…

medicine.medical_specialtyHepatologybusiness.industryGeneral surgeryGastroenterologyMEDLINEEvidence-based medicineDiseasemedicine.diseaseAsymptomaticPancreatic fistulamedicinePortal hypertensionPancreatitismedicine.symptombusinessExocrine pancreatic insufficiency
researchProduct

Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation - authors’ reply

2012

medicine.medical_specialtyHepatologybusiness.industryGeneral surgeryGastroenterologymedicine.diseaseGastroenterologyInternal medicineHepatocellular carcinomahepatocellular carcinoma transarterial chemoembolisationmedicinePharmacology (medical)Liver dysfunctionbusinessAlimentary Pharmacology & Therapeutics
researchProduct

Minimally invasive gastrectomy: time to change practice?

2020

medicine.medical_specialtyHepatologybusiness.industryGeneral surgerymedicine.medical_treatmentDissectionGastroenterologyCytoreduction Surgical ProceduresGastrectomyStomach NeoplasmsMedicineHumansGastrectomyLaparoscopybusinessThe lancet. Gastroenterologyhepatology
researchProduct